Medtronic plc (MDT) Financials
PeriodQ1 FY2027FY2026
Published
Medtronic plc reported $9.76 billion in net sales for Q1 FY2027, the quarter ended July 31, 2026, up 13.7% from a year earlier, and net income attributable to Medtronic of $1.47 billion, or $1.14 per diluted share. Operating profit was $1.76 billion, up 22.1%, and free cash flow was $1.29 billion, up 120.9%, as operating cash flow rose on higher collections from customers and lower cash tax and litigation payments. No growth rate in this quarter is week-for-week comparable: fiscal 2027 is a fifty-three-week year and the extra week fell inside this quarter, so every comparison here sets fourteen weeks of trading against thirteen a year earlier. The company estimates the additional week accounted for about half of the reported sales increase.
| Metric | Amount | vs. year ago |
|---|---|---|
| Revenue | $9,756,000,000 | up 13.7% |
| Net income | $1,470,000,000 | up 41.3% |
| Diluted EPS | $1.14 | up 40.7% |
| Operating profit | $1,764,000,000 | up 22.1% |
| Free cash flow | $1,290,000,000 | up 120.9% |
Company details
| Name | Medtronic plc |
|---|---|
| Ticker | MDT |
| CIK | 0001613103 |
| Exchange | NYSE |
| SIC | 3845 |
| Office | Industrial Applications and Services |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Latest period covered | Q1 FY2027, ended 2026-07-31, 10-Q, accession 0001628280-26-060473 |
| Fiscal year end | 04/24 (MM/DD) |
| Next expected filing | 10-Q around 2026-11-24 (predicted) |
Data files
- Financial statementsPage Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included.
- 10-K and 10-Q summaryPage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events.
- 8-K filings and eventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout.
FAQ · Medtronic Q1 FY2027
How much revenue did Medtronic report in Q1 FY2027?
Medtronic plc reported $9.76 billion in net sales for Q1 FY2027, the quarter ended July 31, 2026, up 13.7% from $8.58 billion in the same quarter a year earlier. Fiscal 2027 is a fifty-three-week year for Medtronic and the extra week fell in this quarter, so that growth rate covers one more week of selling than the year-ago quarter and is not week-for-week comparable.
What was Medtronic's earnings per share in Q1 FY2027?
Medtronic plc earned $1.14 per diluted share in Q1 FY2027, against $0.81 in the same quarter a year earlier, on net income attributable to Medtronic of $1.47 billion, up 41.3%. The quarter ran one week longer than the year-ago quarter because fiscal 2027 carries an extra week, so the comparison is not week-for-week. Beyond that extra week, much of the increase sits below the operating line: Medtronic swung to net gains on minority investments from net losses a year earlier, and its effective tax rate fell on the release of reserves for uncertain tax positions. The rise is not operating performance alone.
Was Medtronic profitable in Q1 FY2027?
Yes. Medtronic plc reported operating profit of $1.76 billion in Q1 FY2027, the quarter ended July 31, 2026, up 22.1% from $1.45 billion a year earlier, and net income attributable to Medtronic of $1.47 billion. Neither comparison is week-for-week: the extra week in Medtronic's fifty-three-week fiscal 2027 fell in this quarter, so both figures cover fourteen weeks against thirteen. Net income grew faster than operating profit largely because of items below the operating line, a swing to net gains on minority investments and a lower effective tax rate, rather than operating performance alone.
How much free cash flow did Medtronic generate in Q1 FY2027?
Medtronic plc generated $1.29 billion of free cash flow in Q1 FY2027, the quarter ended July 31, 2026, up 120.9% from $584 million a year earlier, on the company's definition of operating cash flow less additions to property, plant and equipment. That growth rate is not week-for-week comparable: fiscal 2027 is a fifty-three-week year and the extra week fell in this quarter, so the period covers fourteen weeks of trading and collections against thirteen a year earlier. Operating cash flow also rose on higher collections from customers and lower cash tax and litigation payments.
Where can I get Medtronic plc (MDT) financial data in machine-readable form?
Ticker Scout publishes Medtronic plc's financial statements as JSON at https://tickerscout.ai/mdt/financials.json, free, with no API key and no signup. The 10-K and 10-Q narrative and the 8-K events digest are published as Markdown at https://tickerscout.ai/mdt/narrative.md and https://tickerscout.ai/mdt/events.md. Medtronic plc's SEC CIK is 0001613103. Every figure cites the SEC accession number it came from, so it can be checked against sec.gov.
When does Medtronic plc (MDT) next file with the SEC?
Medtronic plc (MDT) is expected to file its next Form 10-Q with the SEC on or around November 24, 2026. That date is a projection rather than a company-announced date: it is derived from Medtronic plc's own filing history with the SEC, by taking the date the company filed the same fiscal period a year earlier and adding 52 weeks. The most recent periodic report on file is the 10-Q for Q1 FY2027, the period ended 2026-07-31, SEC accession 0001628280-26-060473.
Related companies
How this page was built
This page was built from Medtronic plc's own filings with the SEC, read one at a time, and nothing on it is taken from a pre-tagged dataset, a data vendor or another website. The figures are on the company's own fiscal calendar and in actual dollars, as the filings report them. Where the filings do not support a figure, the record says so instead of reporting a zero; this period names five such gaps.
A single company files thousands of pages with the SEC in a year, and no two companies file them the same way, so the reading and the assembly here are done by AI rather than by rules that break on the differences. Every pass is then audited back against the filings it came from before the page is published, and anything the filings do not support is left out and named rather than filled in. AI can still make mistakes. That is why the accession numbers are printed: the filing is the authority, and this page is a route to it.
Published by Ticker Scout, an independent publisher of company filings data. About Ticker Scout · Disclaimer
Data extracted from SEC filings (accession numbers cited in each file). The undated URLs hold the latest period and are replaced in place each quarter; every period also stays published at its own dated URL, which never changes. Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.